Neurofilament Light Chain Is a Novel Biomarker for Major Depression and Related Executive Dysfunction | Zendy

MuHong Chen | Zendy; YuLi Liu | Zendy; HsiangWei Kuo | Zendy; ShihJen Tsai | Zendy; JuWei Hsu | Zendy; KaiLin Huang | Zendy; PeiChi Tu | Zendy; YaMei Bai | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neurofilament Light Chain Is a Novel Biomarker for Major Depression and Related Executive Dysfunction

Author(s) -

MuHong Chen,

YuLi Liu,

HsiangWei Kuo,

ShihJen Tsai,

JuWei Hsu,

KaiLin Huang,

PeiChi Tu,

YaMei Bai

Publication year - 2021

Publication title -

the international journal of neuropsychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 107

eISSN - 1469-5111

pISSN - 1461-1457

DOI - 10.1093/ijnp/pyab068

Subject(s) - proinflammatory cytokine , executive dysfunction , biomarker , depression (economics) , major depressive disorder , psychology , medicine , bipolar disorder , oncology , psychiatry , cognition , inflammation , neuropsychology , biology , biochemistry , macroeconomics , economics

Evidence suggests that major depressive disorder is related to neuroaxonal injury and that neurofilament light chain (NfL) is a biomarker of neuroaxonal injury. In addition, proinflammatory cytokines have been reported to be associated with major depression and neuroaxonal injury.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research